Résultats de la vérification pour : novartis.com
-
novartis.com est EN LIGNE
Info supplémentaires pour https://novartis.com
Informations Techniques
| Code de Statut HTTP | 200 |
|---|---|
| Version HTTP | HTTP/1.1 |
| HTTPS | ✔ Disponible |
| Adresse IP | 104.18.1.16 |
| Logiciel Serveur | cloudflare |
| CDN | Cloudflare |
| Compression | gzip |
| ℹ 🔵 Content Security Policy Manquante | CSP n'est pas configuré. Cela aide à prévenir les attaques XSS et l'injection de contenu. |
Code de Statut HTTP 200
Version HTTP HTTP/1.1
HTTPS ✔ Disponible
Adresse IP 104.18.1.16
Logiciel Serveur cloudflare
CDN Cloudflare
Compression gzip
ℹ 🔵 Content Security Policy Manquante CSP n'est pas configuré. Cela aide à prévenir les attaques XSS et l'injection de contenu.
Version HTTP HTTP/1.1
HTTPS ✔ Disponible
Adresse IP 104.18.1.16
Logiciel Serveur cloudflare
CDN Cloudflare
Compression gzip
ℹ 🔵 Content Security Policy Manquante CSP n'est pas configuré. Cela aide à prévenir les attaques XSS et l'injection de contenu.
Chaîne de Redirection
| # | URL | Code de Statut HTTP | Statut |
|---|---|---|---|
| 1 | https://novartis.com:443 | 301 | HTTP/2 301 |
| 2 | https://www.novartis.com/ | 200 | HTTP/2 200 |
#1 URL https://novartis.com:443
Code de Statut HTTP 301
Statut HTTP/2 301
#2 URL https://www.novartis.com/
Code de Statut HTTP 200
Statut HTTP/2 200
Code de Statut HTTP 301
Statut HTTP/2 301
#2 URL https://www.novartis.com/
Code de Statut HTTP 200
Statut HTTP/2 200
Performance
| Résolution DNS | 13.6 ms |
|---|---|
| Connexion TCP | 15.5 ms |
| Négociation TLS | 6.9 ms |
| Temps Jusqu'au Premier Octet (TTFB) | 391.2 ms |
| Téléchargement du Contenu | 0.9 ms |
| Temps de Réponse Total | 392.1 ms |
Résolution DNS 13.6 ms
Connexion TCP 15.5 ms
Négociation TLS 6.9 ms
Temps Jusqu'au Premier Octet (TTFB) 391.2 ms
Téléchargement du Contenu 0.9 ms
Temps de Réponse Total 392.1 ms
Connexion TCP 15.5 ms
Négociation TLS 6.9 ms
Temps Jusqu'au Premier Octet (TTFB) 391.2 ms
Téléchargement du Contenu 0.9 ms
Temps de Réponse Total 392.1 ms
Sécurité
| HTTPS | ✔ Activé |
|---|---|
| HSTS | ✔ max-age=31536000; includeSubDomains |
| CSP | ⚠ Non configuré |
| X-Frame-Options | ✔ SAMEORIGIN |
| X-Content-Type-Options | ✔ nosniff |
| HTTP/2 | ⚠ HTTP/1.1 |
HTTPS ✔ Activé
HSTS ✔ max-age=31536000; includeSubDomains
CSP ⚠ Non configuré
X-Frame-Options ✔ SAMEORIGIN
X-Content-Type-Options ✔ nosniff
HTTP/2 ⚠ HTTP/1.1
HSTS ✔ max-age=31536000; includeSubDomains
CSP ⚠ Non configuré
X-Frame-Options ✔ SAMEORIGIN
X-Content-Type-Options ✔ nosniff
HTTP/2 ⚠ HTTP/1.1
Vérification SEO Rapide
| Titre | Novartis |
|---|---|
| Meta Description | For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients. |
| Canonique | https://www.novartis.com/ |
| Titre Open Graph | Novartis |
| Description Open Graph | For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients. |
| Image Open Graph | https://www.novartis.com/sites/novartis_com/files/2023-11... |
| Twitter Card | summary_large_image |
| Titre Twitter | Novartis |
| Description Twitter | For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients. |
| Image Twitter | https://www.novartis.com/sites/novartis_com/files/novarti... |
Titre Novartis
Meta Description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Canonique https://www.novartis.com/
Titre Open Graph Novartis
Description Open Graph For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Image Open Graph https://www.novartis.com/sites/novartis_com/files/2023-11...
Twitter Card summary_large_image
Titre Twitter Novartis
Description Twitter For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Image Twitter https://www.novartis.com/sites/novartis_com/files/novarti...
Meta Description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Canonique https://www.novartis.com/
Titre Open Graph Novartis
Description Open Graph For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Image Open Graph https://www.novartis.com/sites/novartis_com/files/2023-11...
Twitter Card summary_large_image
Titre Twitter Novartis
Description Twitter For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Image Twitter https://www.novartis.com/sites/novartis_com/files/novarti...
Technologies Détectées
| Technologie | Drupal Google Analytics Google Tag Manager Cloudflare |
|---|
Technologie Drupal Google Analytics Google Tag Manager Cloudflare
En-têtes HTTP
| Date | Wed, 29 Jul 2026 23:28:44 GMT |
|---|---|
| Content-type | text/html; charset=UTF-8 |
| Server | cloudflare |
| Cache-control | must-revalidate, no-cache, private |
| X-dns-prefetch-control | off |
| Content-language | en |
| X-content-type-options | nosniff |
| X-frame-options | SAMEORIGIN |
| Expires | Sun, 19 Nov 1978 05:00:00 GMT |
| Server-timing | cfEdge;dur=24,cfOrigin;dur=332 |
| Content-security-policy-report-only | script-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://cfvod.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob: https://vjs.zencdn.net/5.0/video.min.js https://analytics.tiktok.com; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com https://cfvod.kaltura.com https://vjs.zencdn.net/5.0/video-js.min.css https://analytics.tiktok.com; frame-ancestors 'self' |
| X-xss-protection | 1; mode=block |
| Strict-transport-security | max-age=31536000; includeSubDomains |
| Set-cookie | __cf_bm=p1v.7DQI8VfOuA.5NpbRDOtLW59oIYT1XP0i1OBMeOQ-1785367724.3654995-1.0.1.1-0slMftGbAFT28HJIQkYI6Bg35a33WbpZjh1Z.Qs73G.b3_BdwwTh2f7sMZFmppZ5g9IBM3B1bM9KMQWwkoJC8KnsEhjcM3FKjHCB17xgbY6UrSCDibYTRkNyjY2u72j1; HttpOnly; SameSite=None; Secure; Path=/; Domain=novartis.com; Expires=Wed, 29 Jul 2026 23:58:44 GMT |
| X-request-id | v-3d900b12-8ba5-11f1-8a8d-1f3a41dbccf2 |
| X-ah-environment | prod |
| X-geo-country | FR |
| Vary | Accept-Encoding,X-Geo-Country |
| Via | varnish |
| X-cache | MISS |
| Cf-cache-status | BYPASS |
| Content-encoding | gzip |
| Cf-ray | a22fe6d5486ad0af-CDG |
Balises Meta
| Description | For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients. |
|---|---|
| Abstract | For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients. |
| Keywords | novartis, reimagining medicines |
| Msvalidate.01 | 8D3EBDFBAAB1FF3ED7947B6A7DFD293D |
| Google-site-verification | oWLifsm3cWEQxnH7h2q7auXVJgDapVcYDRjNg1rESi4 |
| MobileOptimized | width |
| HandheldFriendly | true |
| Viewport | width=device-width, initial-scale=1, shrink-to-fit=no |
| X-ua-compatible | ie=edge |
| Theme-color | #ffffff |
Date Wed, 29 Jul 2026 23:28:44 GMT
Content-type text/html; charset=UTF-8
Server cloudflare
Cache-control must-revalidate, no-cache, private
X-dns-prefetch-control off
Content-language en
X-content-type-options nosniff
X-frame-options SAMEORIGIN
Expires Sun, 19 Nov 1978 05:00:00 GMT
Server-timing cfEdge;dur=24,cfOrigin;dur=332
Content-security-policy-report-only script-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://cfvod.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob: https://vjs.zencdn.net/5.0/video.min.js https://analytics.tiktok.com; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com https://cfvod.kaltura.com https://vjs.zencdn.net/5.0/video-js.min.css https://analytics.tiktok.com; frame-ancestors 'self'
X-xss-protection 1; mode=block
Strict-transport-security max-age=31536000; includeSubDomains
Set-cookie __cf_bm=p1v.7DQI8VfOuA.5NpbRDOtLW59oIYT1XP0i1OBMeOQ-1785367724.3654995-1.0.1.1-0slMftGbAFT28HJIQkYI6Bg35a33WbpZjh1Z.Qs73G.b3_BdwwTh2f7sMZFmppZ5g9IBM3B1bM9KMQWwkoJC8KnsEhjcM3FKjHCB17xgbY6UrSCDibYTRkNyjY2u72j1; HttpOnly; SameSite=None; Secure; Path=/; Domain=novartis.com; Expires=Wed, 29 Jul 2026 23:58:44 GMT
X-request-id v-3d900b12-8ba5-11f1-8a8d-1f3a41dbccf2
X-ah-environment prod
X-geo-country FR
Vary Accept-Encoding,X-Geo-Country
Via varnish
X-cache MISS
Cf-cache-status BYPASS
Content-encoding gzip
Cf-ray a22fe6d5486ad0af-CDG
Content-type text/html; charset=UTF-8
Server cloudflare
Cache-control must-revalidate, no-cache, private
X-dns-prefetch-control off
Content-language en
X-content-type-options nosniff
X-frame-options SAMEORIGIN
Expires Sun, 19 Nov 1978 05:00:00 GMT
Server-timing cfEdge;dur=24,cfOrigin;dur=332
Content-security-policy-report-only script-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://cfvod.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob: https://vjs.zencdn.net/5.0/video.min.js https://analytics.tiktok.com; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com https://cfvod.kaltura.com https://vjs.zencdn.net/5.0/video-js.min.css https://analytics.tiktok.com; frame-ancestors 'self'
X-xss-protection 1; mode=block
Strict-transport-security max-age=31536000; includeSubDomains
Set-cookie __cf_bm=p1v.7DQI8VfOuA.5NpbRDOtLW59oIYT1XP0i1OBMeOQ-1785367724.3654995-1.0.1.1-0slMftGbAFT28HJIQkYI6Bg35a33WbpZjh1Z.Qs73G.b3_BdwwTh2f7sMZFmppZ5g9IBM3B1bM9KMQWwkoJC8KnsEhjcM3FKjHCB17xgbY6UrSCDibYTRkNyjY2u72j1; HttpOnly; SameSite=None; Secure; Path=/; Domain=novartis.com; Expires=Wed, 29 Jul 2026 23:58:44 GMT
X-request-id v-3d900b12-8ba5-11f1-8a8d-1f3a41dbccf2
X-ah-environment prod
X-geo-country FR
Vary Accept-Encoding,X-Geo-Country
Via varnish
X-cache MISS
Cf-cache-status BYPASS
Content-encoding gzip
Cf-ray a22fe6d5486ad0af-CDG
Description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Abstract For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Keywords novartis, reimagining medicines
Og:site_name Novartis
Og:type Website
Og:url https://www.novartis.com/home
Og:title Novartis
Og:description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Og:image
Og:image:url
Og:image:secure_url
Og:image:alt Novartis logo
Twitter:card summary_large_image
Twitter:title Novartis
Twitter:site @novartis
Twitter:description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Twitter:site:id 17226612
Twitter:creator:id 17226612
Twitter:creator @novartis
Twitter:image:alt Novartis logo
Twitter:image
Msvalidate.01 8D3EBDFBAAB1FF3ED7947B6A7DFD293D
Google-site-verification oWLifsm3cWEQxnH7h2q7auXVJgDapVcYDRjNg1rESi4
MobileOptimized width
HandheldFriendly true
Viewport width=device-width, initial-scale=1, shrink-to-fit=no
X-ua-compatible ie=edge
Theme-color #ffffff
Abstract For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Keywords novartis, reimagining medicines
Og:site_name Novartis
Og:type Website
Og:url https://www.novartis.com/home
Og:title Novartis
Og:description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Og:image
Og:image:url
Og:image:secure_url
Og:image:alt Novartis logo
Twitter:card summary_large_image
Twitter:title Novartis
Twitter:site @novartis
Twitter:description For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Twitter:site:id 17226612
Twitter:creator:id 17226612
Twitter:creator @novartis
Twitter:image:alt Novartis logo
Twitter:image
Msvalidate.01 8D3EBDFBAAB1FF3ED7947B6A7DFD293D
Google-site-verification oWLifsm3cWEQxnH7h2q7auXVJgDapVcYDRjNg1rESi4
MobileOptimized width
HandheldFriendly true
Viewport width=device-width, initial-scale=1, shrink-to-fit=no
X-ua-compatible ie=edge
Theme-color #ffffff
Non-stop browsing
& internet stability
Best VPN in AdBlocking & Malware detection
& internet stability
Best VPN in AdBlocking & Malware detection
Offre limitée, ne tardez pas !:

